Current Gene Therapy : Impact Factor & More
eISSN: 1875-5631pISSN: 1566-5232
Share this on:
Aims and Scope of Current Gene Therapy
Current Gene Therapy is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Liang Cheng (Harbin Medical University Harbin, China). The focus of this journal is pre-clinical or clinical research on gene therapy. Formats of publication include original research reports, review papers, and rapid communications ("letters"). Less
Key Metrics
CiteScore 
5.8
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q3Genetics
SNIP
0.89
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Current Gene Therapy
Current Gene Therapy Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2000 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Gene Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Current Gene Therapy
A Complement and Coagulation Cascade-Related Prognostic Signature Predicts Survival and Immune Landscape in Lung Adenocarcinoma.
- 7 May 2026
- Current gene therapy
Macrophage-related Genes were Discovered by Applying Highdimensional Weighted Gene Co-expression Network Analysis as Biomarkers for Esophageal Squamous Cell Carcinoma.
- 6 May 2026
- Current gene therapy
An Epithelial-Mesenchymal Transition-Based Prognostic Model for Survival Prediction in Lung Adenocarcinoma: COL5A2 and ZEB2.
- 5 May 2026
- Current gene therapy
Hutchinson-Gilford Progeria Syndrome: Genetic Insights, Clinical Challenges, and Innovative Therapeutic Approaches.
- 5 May 2026
- Current gene therapy
Construction of a Vasculogenic Mimicry-related RiskScore Model to Assess Patient Prognosis and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma.
- 30 Apr 2026
- Current gene therapy
Sotagliflozin Ameliorates LPS‑Induced Cardiomyocyte Injury by Regulating the PI3K‑Akt and Extracellular Matrix-Related Pathways.
- 28 Apr 2026
- Current gene therapy
A Complement and Coagulation Cascade-Related Prognostic Signature Predicts Survival and Immune Landscape in Lung Adenocarcinoma.
- 7 May 2026
- Current gene therapy
Macrophage-related Genes were Discovered by Applying Highdimensional Weighted Gene Co-expression Network Analysis as Biomarkers for Esophageal Squamous Cell Carcinoma.
- 6 May 2026
- Current gene therapy
An Epithelial-Mesenchymal Transition-Based Prognostic Model for Survival Prediction in Lung Adenocarcinoma: COL5A2 and ZEB2.
- 5 May 2026
- Current gene therapy
Hutchinson-Gilford Progeria Syndrome: Genetic Insights, Clinical Challenges, and Innovative Therapeutic Approaches.
- 5 May 2026
- Current gene therapy
Construction of a Vasculogenic Mimicry-related RiskScore Model to Assess Patient Prognosis and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma.
- 30 Apr 2026
- Current gene therapy
Sotagliflozin Ameliorates LPS‑Induced Cardiomyocyte Injury by Regulating the PI3K‑Akt and Extracellular Matrix-Related Pathways.
- 28 Apr 2026
- Current gene therapy
FAQs on Current Gene Therapy
How long has Current Gene Therapy been actively publishing? 
What is the publishing frequency of Current Gene Therapy?
How many articles did Current Gene Therapy publish last year?
What is the eISSN & pISSN for Current Gene Therapy?
What is Citescore for Current Gene Therapy?
What is SNIP score for Current Gene Therapy?
What is the SJR for Current Gene Therapy?
Who is the publisher of Current Gene Therapy?
